. "Appendix B: Biographic Information on Invited Speakers, Panelists, and Authors of Commissioned Papers." Public Health Effectiveness of the FDA 510(k) Clearance Process: Measuring Postmarket Performance and Other Select Topics: Workshop Report. Washington, DC: The National Academies Press, 2011.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Public Health Effectiveness of the FDA 510(k) Clearance Process: Measuring Postmarket Performance and Other Select Topics - Workshop Report
clinical training at Montefiore Medical Center in the Bronx, New York, and at Children’s National Medical Center in Washington, DC.
Robert E. Fischell, ScD, was employed at the Johns Hopkins University Applied Physics Laboratory full-time for 25 years and part-time for an additional 13 years. At Johns Hopkins, Dr. Fischell was the chief engineer of the Space Department, where he worked on more than 50 spacecraft. His interests at Johns Hopkins then turned to the invention of new medical devices, such as pacemakers and implantable heart defibrillators. Starting in 1969, Dr. Fischell began the formation of 14 private companies that licensed his patents on medical devices. The companies included Pacesetter Systems Inc. (now called St. Jude Medical), IsoStent Inc., NeuroPace Inc., Neuralieve Inc., Angel Medical Systems Inc., and Svelte Medical Systems Inc. Dr. Fischell has over 150 issued US and foreign patents for medical devices. Dr. Fischell is a trustee of the University of Maryland College Park Foundation and a member of the Board of Visitors for the College of Engineering and the College of Computer, Mathematical, and Physical Sciences and the University of Maryland School of Medicine. Dr. Fischell’s was elected to the National Academy of Engineering in 1989. He has received numerous awards for his contributions including the Inventor of the Year for the USA in 1984; Distinguished Physics Alumnus Award of the University of Maryland; the 2004 Discover magazine award for Technology for Humanity; the 2005 TED award; the 2007 Master Inventor award from the Applied Physics Laboratory, and the Woodrow Wilson Prize for Public Service from the Woodrow Wilson Society for Scholars, as well as several other medals for his accomplishments in science, engineering, and innovation. In 2005, he gave $30 million to create and fund the Fischell Department of Bioengineering in the Clark School of Engineering. In that same year, the University of Maryland created the Robert E. Fischell Institute for Medical Devices to further the pioneering work that Dr. Fischell has created. Dr. Fischell received his BSME from Duke University and MS and ScD degrees from the University of Maryland.
Kevin Fu, PhD, is an assistant professor in the Department of Computer Science of the University of Massachusetts Amherst. Prof. Fu investigates how to achieve trustworthy computing for embedded devices that must withstand both unintentional interference and determined, malicious intent. Prof. Fu’s research contributions range from the design and implementation of cryptographic systems to the security-risk analysis of computer systems, such as implantable cardiac defibrillators, automated software updates, contactless no-swipe credit cards, and Web site log-in systems. He is an Alfred P. Sloan Research Fellow, MIT Technology Review TR35 Innovator of the Year, and recipient of the National Science Foundation CAREER award.